Immunic Therapeutics

Immunic Therapeutics

Verified
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company
Planegg Germany (HQ), San Diego United States

Company information

Edit
Launch date
Employees
24 people
Ownership
Firm valuation
€40—60m (Dealroom.co estimates Sep 2017.)
  • Edit
DateInvestorsAmountRound
€17.5mSERIES A
N/A€4mSERIES A
€10mSERIES A
*
€650kGRANT
Total Funding€32.2m

Recent News about Immunic Therapeutics

Edit
Are you an employee or an investor of this company?
Add your profile